Aggregator
Rihanna and A$AP Rocky’s daughter Rocki nabs her second magazine cover before her first birthday
New York, New Jersey Hasidic leaders meet Trump, Vance in ‘historic’ Oval Office summit
PayPal to slash hundreds of California jobs as big money managers axed by tech giant
Why NYC widower wants driver charged with antisemitic hate crime months after wife was killed in hit-and-run crash
America’s population of 401(k) millionaires hits record high — thanks to strong market
WNBA’s next commissioner will have to check a lot of boxes — before the critical work begins
Pentagon, HHS Investigating Whether COVID Vaccines Contributed To Military Deaths
Authored by AG News Staff via American Greatness,
The Trump administration is investigating whether COVID-19 vaccines contributed to the deaths of U.S. service members following the Biden administration's military vaccine mandate, according to testimony from an Army doctor assigned to the effort.
Army physician Theresa Long said in an Aug. 14 federal court deposition that Defense Secretary Pete Hegseth detailed her to serve as Health Secretary Robert F. Kennedy Jr.'s senior medical military adviser.
Long said she is examining 2,544 unverified reports of deaths among service members submitted to the federal Vaccine Adverse Event Reporting System, or VAERS, following COVID vaccination.
VAERS is an early-warning surveillance system that accepts reports of health problems occurring after vaccination. A report does not establish that a vaccine caused the medical event or death.
Long, who is board certified in aerospace medicine and holds a master's degree in public health, said she hopes to complete her investigation within a year.
She also testified that she knows of 28 people who died because of COVID vaccines but said she was not permitted to provide additional information supporting that assertion.
The investigation comes as the Trump administration reexamines the military's handling of the COVID pandemic and the Biden administration's 2021 vaccine mandate.
Nearly 9,000 service members were discharged for refusing COVID vaccinations before Congress ordered the Pentagon to rescind the mandate in 2022. The Defense Department has since established a COVID-19 Reinstatement and Reconciliation Task Force to assist troops who left the military over the requirement and want to return.
"The Department continues to right the wrongs of the past and to restore confidence in, and honor to, our fighting force," the Pentagon said in announcing the task force.
Long is also reviewing military health surveillance systems and two medical databases from the pandemic period.
A 2026 Pentagon report found an increase in myocarditis and pericarditis among active-duty service members shortly after COVID vaccination, but said the increase was not sustained over one year. The report did not identify vaccine-related deaths.
The FDA has also required updated warnings for mRNA COVID vaccines concerning myocarditis and pericarditis. The agency reported a higher incidence among young men, with 27 cases per million vaccinations compared with 8 per million in the general population for the period it analyzed.
Long's previously undisclosed assignment indicates that the Trump administration's review of the Biden-era military vaccine mandate now extends beyond reinstating discharged troops to examining whether the vaccines themselves caused serious injuries or deaths among service members.
Tyler Durden Fri, 09/04/2026 - 15:00Mets vs. Giants, Red Sox vs. Orioles prediction, odds: MLB picks, best bets Friday
‘The Gentlemen’ Season 2 Episode 4 Recap: The Falcon Cannot Hear the Falconer
How to watch Serena and Venus Williams in the US Open 2026 doubles tournament: Time, streaming
How to watch Serena and Venus Williams in the US Open 2026 doubles tournament: Time, streaming
Inside the high school game that turned Jaxson Dart into a star: ‘We gotta get this dude’
Urgent warning as rabid bat cases surge in elite California college town
Smuggler nabbed at California border with massive supply of cancer-causing chemicals
‘Pawn Stars’ staple undergoes emergency bypass surgery
‘Pawn Stars’ staple undergoes emergency bypass surgery
Deutsche Bank: August US Auto Sales Beat Forecasts, But Incentives Remain A Factor
U.S. auto sales came in stronger than expected in August, offering another sign that consumer demand for new vehicles remains relatively resilient despite elevated borrowing costs and broader questions about the economy.
According to Deutsche Bank’s auto team, led by Edison Yu, August sales ran at a seasonally adjusted annual rate of roughly 16.9 million vehicles. That was comfortably ahead of the bank’s 16.4 million estimate and also above the roughly 16.4 million pace recorded a year earlier.
The headline SAAR number was strong, although the underlying monthly figures were somewhat less impressive. Automakers sold approximately 1.388 million vehicles during August, slightly above July’s 1.380 million but below the roughly 1.482 million vehicles sold in August 2025.
Sales among both the Detroit Three and major Japanese automakers were modestly better than Deutsche Bank expected. But Hyundai Group was one of the biggest contributors to the upside surprise, beating the bank’s forecast by approximately 14,000 vehicles. Other brands accounted for the remainder of the beat.
The closely watched large pickup market was more mixed. Daily sales declined for most major truck models, but Ram was a notable exception. Ram sales increased by roughly 105 vehicles per day to around 1,550, with Deutsche Bank attributing much of that strength to aggressive incentive spending.
Higher sales are obviously positive for volumes, but when they are being generated through heavier discounts and incentives, the improvement doesn’t necessarily translate into equally strong profitability for manufacturers.
Inventory remains relatively controlled. Industry-wide inventories slipped to approximately 49 days of supply, compared with 50 days previously, although that remains above the 47-day level seen in 2025. Truck inventories declined by one day to 52 days of supply, while passenger-car inventories dropped by two days to just 34.
Taken together, the August numbers paint a reasonably healthy picture of the U.S. auto market. Sales are running better than expected, inventories aren’t showing signs of a major glut, and the annualized selling rate remains comfortably above 16 million vehicles.
Deutsche Bank isn’t extrapolating August’s 16.9 million pace into a dramatically stronger industry forecast, however. Yu and his team continue to expect a 16.0 million SAAR for full-year 2026, roughly consistent with forecasts from the major automakers themselves. For 2027, Deutsche Bank is forecasting only a modest improvement to 16.1 million.
In other words, August was a good month, but Deutsche Bank isn’t calling it the beginning of an auto boom. The more interesting question from here may be how much manufacturers have to spend on incentives to keep sales around these levels...particularly if consumers remain squeezed by high vehicle prices and financing costs.
Tyler Durden Fri, 09/04/2026 - 14:40